Shaolin Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Shaolin Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$90K	–	468
2023 Q4	$90K	Sell	300,000 -150,000	-33%	-$46.3K	﹤0.01%	194
2023 Q3	$157K	Sell	450,000 -56,323	-11%	-$14.8K	0.01%	242
2023 Q2	$81K	Hold	506,323	–	–	﹤0.01%	336
2023 Q1	$73K	Hold	506,323	–	–	﹤0.01%	405
2022 Q4	$30K	Hold	506,323	–	–	﹤0.01%	530
2022 Q3	$20K	Hold	506,323	–	–	﹤0.01%	722
2022 Q2	$56K	Hold	506,323	–	–	﹤0.01%	676
2022 Q1	$91K	Hold	506,323	–	–	﹤0.01%	666
2021 Q4	$162K	Buy	+506,323	New	+$160K	﹤0.01%	606

Shaolin Capital Management's DMAQR Position: Q1 2024 in Review

Shaolin Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 300,000 shares — an estimated $90K sold.

Shaolin Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $162K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Shaolin Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Shaolin Capital Management sold 300,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $90K.
Shaolin Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Shaolin Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $162K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Shaolin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.